What 2 P2 (lung and breast) cancer trials with good top line results with 1 compound mind you, will do, 370% gain within the last 12 months, NASDAQ listing, almost 7 Bil market cap. Not too shabby. Let's get our Cellceutix P2 Kevetrin trials show on the road..............................shoulda been a doctor, LOL.